Engineering Resilient CAR-NK Cell Therapies, Innovations from the Rezvani Lab to Treat Patients with CAR-NK Therapies More Effectively
- Developing safer and more effective CAR-NK therapies from cord blood to treat a range of cancers from lymphoma leukaemia to breast cancer
- Enhancing NK cell function through gene editing and checkpoint discovery
- Expanding applications to solid tumors with scalable off-the-shelf products